|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.270 USD | +2.42% |
|
-5.22% | -14.77% |
| Market Cap | 20.67M 18.18M 16.89M 15.54M 29.14M 2B 29.66M 202M 78.79M 977M 77.62M 75.94M 3.39B | P/E 2026 * |
-1.29x | P/E 2027 * | -1.22x |
|---|---|---|---|---|---|
| Enterprise Value | 20.67M 18.18M 16.89M 15.54M 29.14M 2B 29.66M 202M 78.79M 977M 77.62M 75.94M 3.39B | EV / Sales 2026 * |
7.3x | EV / Sales 2027 * | 1.03x |
| Free-Float |
94.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Marker Therapeutics, Inc.
| 21-08-20 | Wall Street hoger gesloten | |
| 21-08-20 | Wall Street koerst af op hoger slot | |
| 21-08-20 | Wall Street richting lagere opening |
| 1 day | +2.42% | ||
| 1 week | -5.22% | ||
| Current month | -13.61% | ||
| 1 month | -7.30% | ||
| 3 months | -12.41% | ||
| 6 months | -39.52% | ||
| Current year | -14.77% |
| 1 week | 1.22 |  | 1.38 |
| 1 month | 1.22 | | 1.72 |
| Current year | 1.17 | | 2.46 |
| 1 year | 0.81 | | 2.46 |
| 3 years | 0.81 | | 9.68 |
| 5 years | 0.67 | | 22.99 |
| 10 years | 0.67 | | 135.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 46 | 2023-04-30 |
| Chief Operating Officer | 36 | 2023-11-30 | |
Patricia Allison
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Juan Vera
BRD | Director/Board Member | 46 | 2018-10-16 |
Norman Eansor
CHM | Chairman | 65 | 2022-05-23 |
Steven Elms
BRD | Director/Board Member | 62 | 2019-08-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/17/25 | Free | Director | 221,741 | 1.7138% | ||
| 11/17/25 | Free | Chairman | 221,741 | 1.7138% | ||
| 11/17/25 | Free | Director | 221,741 | 1.7138% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.42% | -5.22% | -20.62% | -83.72% | 20.67M | |
| +1.08% | -6.74% | -2.31% | +10.45% | 46.06B | |
| +3.13% | +5.34% | +402.93% | +627.64% | 38.91B | |
| +2.14% | +2.95% | +10.83% | +67.37% | 35.57B | |
| +4.43% | -1.51% | +6.73% | -9.13% | 33.13B | |
| +1.23% | -1.99% | -0.05% | +30.76% | 26.42B | |
| +0.29% | -2.75% | - | - | 16.61B | |
| +14.71% | +12.62% | +38.50% | +145.33% | 15.08B | |
| -6.32% | -4.59% | +4.36% | +8.22% | 14.08B | |
| +1.82% | +0.19% | +1.45% | -29.80% | 12.81B | |
| Average | +2.58% | -3.12% | +49.09% | +85.23% | 23.87B | |
| Weighted average by Cap. | +2.60% | -2.47% | +75.83% | +133.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.83M 2.49M 2.31M 2.13M 3.99M 274M 4.06M 27.65M 10.79M 134M 10.63M 10.4M 464M | 20.09M 17.67M 16.41M 15.09M 28.31M 1.95B 28.81M 196M 76.54M 949M 75.41M 73.77M 3.29B |
| Net income | -19.36M -17.03M -15.82M -14.55M -27.29M -1.88B -27.77M -189M -73.79M -915M -72.69M -71.12M -3.17B | -19.89M -17.49M -16.25M -14.95M -28.03M -1.93B -28.53M -194M -75.81M -940M -74.68M -73.06M -3.26B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | US$1.270 | +2.42% | 14,250 |
| 26-07-22 | US$1.240 | -2.36% | 42,583 |
| 26-07-21 | US$1.270 | -0.78% | 26,191 |
| 26-07-20 | US$1.280 | -2.29% | 58,384 |
| 26-07-17 | US$1.310 | -2.24% | 30,877 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRKR Stock
Select your edition
All financial news and data tailored to specific country editions
